Clinical Trial Update: Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing SGLT2 inhibitor therapy to an ACE inhibitor for diabetic nephropathy (Phase 2/3) with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• ACE inhibitor (angiotensin-converting enzyme inhibitor)
• SGLT2 inhibitor

Snippet

Sponsor: Omar Tarek Elfarargi | Conditions: Diabetic Nephropathy Type 2 | Phase 2, Phase 3 | Status: UNKNOWN